MAXIPHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 87375617
Søren Nymarks Vej 25, 8270 Højbjerg
tel: 86292955
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 431.93 | 1 534.43 | 1 682.82 | 2 022.23 | 1 824.62 |
| Employee benefit expenses | - 857.26 | - 889.42 | - 971.39 | -1 044.58 | -1 286.55 |
| Total depreciation | -67.16 | -64.99 | -57.15 | -7.66 | |
| EBIT | 507.50 | 580.03 | 654.27 | 969.99 | 538.08 |
| Other financial income | 562.16 | 435.91 | 630.05 | 18.66 | 475.08 |
| Other financial expenses | -77.36 | -59.02 | -17.08 | - 648.82 | - 722.73 |
| Pre-tax profit | 992.31 | 956.93 | 1 267.23 | 339.83 | 290.44 |
| Income taxes | - 218.31 | - 210.54 | - 278.89 | -74.89 | -63.95 |
| Net earnings | 774.00 | 746.39 | 988.34 | 264.94 | 226.48 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 129.80 | 64.82 | 7.66 | ||
| Tangible assets total | 129.80 | 64.82 | 7.66 | ||
| Other receivables | 174.60 | 174.60 | 174.60 | 174.60 | 174.60 |
| Investments total | 174.60 | 174.60 | 174.60 | 174.60 | 174.60 |
| Long term receivables total | |||||
| Finished products/goods | 1 550.72 | 1 017.46 | 1 607.67 | 1 564.04 | 1 228.28 |
| Inventories total | 1 550.72 | 1 017.46 | 1 607.67 | 1 564.04 | 1 228.28 |
| Current trade debtors | 1 690.06 | 1 639.57 | 1 223.16 | 1 437.05 | 1 303.41 |
| Current amounts owed by group member comp. | 225.79 | 64.31 | |||
| Prepayments and accrued income | 13.60 | 13.57 | 13.49 | 25.63 | 154.57 |
| Current other receivables | 217.76 | ||||
| Current deferred tax assets | 3.07 | 11.28 | 19.02 | 16.81 | 13.63 |
| Short term receivables total | 1 706.73 | 1 664.42 | 1 255.68 | 1 705.28 | 1 753.67 |
| Other current investments | 287.81 | 258.61 | 1 137.64 | 1 633.30 | 2 021.76 |
| Cash and bank deposits | 1 234.09 | 1 693.56 | 885.35 | 19.52 | 27.94 |
| Cash and cash equivalents | 1 521.90 | 1 952.16 | 2 022.99 | 1 652.81 | 2 049.71 |
| Balance sheet total (assets) | 5 083.76 | 4 873.46 | 5 068.60 | 5 096.73 | 5 206.26 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 700.00 | 700.00 | 700.00 | 700.00 | 700.00 |
| Shares repurchased | 200.00 | 700.00 | 204.00 | 204.00 | 204.00 |
| Retained earnings | 1 174.23 | 1 248.22 | 1 790.61 | 2 574.95 | 2 635.89 |
| Profit of the financial year | 774.00 | 746.39 | 988.34 | 264.94 | 226.48 |
| Shareholders equity total | 2 848.22 | 3 394.61 | 3 682.95 | 3 743.89 | 3 766.38 |
| Non-current other liabilities | 13.63 | 36.48 | |||
| Non-current liabilities total | 13.63 | 36.48 | |||
| Current loans from credit institutions | 76.98 | 32.69 | 565.82 | 602.03 | |
| Current trade creditors | 404.99 | 156.27 | 122.29 | 110.61 | 117.71 |
| Current owed to group member | 985.18 | 214.49 | |||
| Short-term deferred tax liabilities | 199.83 | 214.49 | 284.33 | 71.72 | 58.32 |
| Other non-interest bearing current liabilities | 554.93 | 1 038.91 | 764.53 | 604.69 | 661.82 |
| Current liabilities total | 2 221.91 | 1 442.37 | 1 385.65 | 1 352.84 | 1 439.88 |
| Balance sheet total (liabilities) | 5 083.76 | 4 873.46 | 5 068.60 | 5 096.73 | 5 206.26 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.